TransMedics Group (TMDX) Misses Q4 EPS by 4c

TransMedics Group (NASDAQ: TMDX) reported Q4 EPS of ($0.46), $0.04 worse than the analyst estimate of ($0.42). Revenue for the quarter came in at $9.7 million versus the consensus estimate of $7.52 million.

For earnings history and earnings-related data on TransMedics Group (TMDX) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Jefferies on Yeti Holdings Inc. (YETI): 'Reiterate Buy on Today's Weakness'
• Innovative Solutions & Support (ISSC) Tops Q3 EPS by 10c